PFE · 10-Q · 2026Q2 · Full report

Litigation and Legal Risk

PFIZER INC · 2026-08-04 · Importance 83 · Surprise 82

Pfizer recorded $867 million of legal charges in second-quarter 2026 adjustments, primarily for product liability and other legal expenses. Legal charges totaled approximately $1.0 billion for the first six months of 2026, compared with $422 million in the second quarter and $564 million in the first six months of 2025. The increase reduced GAAP other income deductions and was a major difference between GAAP net loss of $248 million and adjusted net income of $4.440 billion in the second quarter.

Key facts